Business Context and Reporting Period
This Form 8-K is a current report filed by CompoSecure, Inc. (not GPGI, Inc.) on October 18, 2024. The filing addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel and governance matters.
Material Changes
- Board Appointment: The Board appointed Dr. Krisha Mikkilineni to fill the vacancy left by the retirement of Niloofar Razi Howe.
- Term and Committee: Dr. Mikkilineni serves as a Class III director until the 2027 annual meeting and will join the Compensation Committee.
- Compensation Arrangement:
- Sign-on equity award (stock options): Grant date value of approximately $200,000.
- Prorated annual award (stock options): Grant date fair value of approximately $125,000.
- Vesting: Both awards vest over a four-year period commencing on the start date of his Board service.
- Indemnification: A customary indemnification agreement was executed.
Outlook, Risks, and Management Commentary
The filing includes a press release (Exhibit 99.1) detailing Dr. Mikkilineni's background, including his role as General Partner of StartupXseed and former 33-year tenure at Honeywell International, Inc. No specific financial guidance, risk factors, or unusual items are disclosed in this report.
Investor Verification Checklist
- Verify the exact vesting schedule and exercise terms of the stock options granted to Dr. Mikkilineni in the definitive equity award agreement.
- Confirm the effective date of Dr. Mikkilineni's Board service to calculate the precise vesting timeline.
- Review the full text of the press release (Exhibit 99.1) for additional context on the strategic rationale for the appointment.
- Check subsequent filings for any changes to the Board composition or compensation policy.